ArticleFrontiers in surgery2026
Comparative study of two minimally invasive transforaminal interbody fusions for single-segment lumbar disc herniation: a retrospective study.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: In this study, we aimed to evaluate and compare the clinical efficacy of unilateral biportal endoscopic transforaminal lumbar interbody fusion (UBE-TLIF) and minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) for the treatment of single-level lumbar disc herniation (LDH). Methods: A total of 60 patients who underwent surgery between January 2023 and January 2024 were retrospectively enrolled and divided into two groups based on the surgical technique: UBE-TLIF ( Results: Following surgery, both groups demonstrated significant longitudinal improvements in visual analog scale (VAS), Oswestry Disability Index (ODI), and Japanese Orthopaedic Association (JOA) scores compared with preoperative levels ( Discussion: Although UBE-TLIF requires a longer operative time than MIS-TLIF, it significantly reduces HBL, VBL, and TBL. Both surgical techniques yield favorable and comparable outcomes in terms of early pain relief, long-term clinical efficacy, and interbody fusion. Therefore, for middle-aged and elderly patients with single-level LDH, although both procedures are highly effective, UBE-TLIF demonstrates specific perioperative advantages in terms of blood conservation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.